Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
http://www.theflyonthewall.com/permalinks/entry.php/PSTIid1359161/PSTI-Pluristem-Therapeutics-target-raised-to--from---at-Roth-Capital
e